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Abstract
Background: Obesity has reached epidemic proportions, affecting more than one tenth of the world’s population. As such,
adipose tissue is being increasingly recognized as an important therapeutic target for obesity and related metabolic
disorders. While many potential targets of adipose tissue have been established and drugs developed, very few of those
drugs specifically target adipose tissue without affecting other tissue. This results from a limited knowledge of both cell-
surface markers and physicochemical traits specific to adipocytes that might otherwise be exploited by circulating drugs.
Methodology/Principal Findings: Here we report the use of cell-SELEX technology to select two aptamers that can
specifically recognize mature adipocytes: adipo-1 and adipo-8. Adipo-8 shows high affinity for differentiated, mature 3T3-L1
adipocytes with a Kd value of 17.865.1 nM. The binding was sustained upon incubation at 37uC and insulin stimulation, but
was lost upon trypsin treatment. The binding ability was also verified on frozen tissue slides with low background
fluorescence and isolated adipocytes.
Conclusions/Significance: Aptamer adipo-8 selected from a random library appears to bind to mature differentiated
adipocytes specifically. This aptamer holds great promise as a molecular recognition tool for adipocyte biomarker discovery
or for targeted delivery of molecules to adipocytes.
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Introduction
Obesity has reached epidemic proportions in most industrial-
ized countries, leading to an increased prevalence of metabolic
syndrome characterized by visceral obesity, hypertension, dyslipi-
demia, and insulin resistance. Adipose tissue has long being viewed
solely as a site for pure fat storage. However, during the last 20
years, adipokines, or adipocytokines, which are cell-to-cell
signaling proteins secreted by adipose tissue, have been studied
and characterized, leading to a surge of scientific interest in
adipocytes. Adipose tissue is primarily composed of adipocytes,
which are cells that store fat as energy, but adipocytes also have an
endocrine function in regulating energy homeostasis and serving as
an integrator of various physiological pathways [1,2,3].
Many studies have demonstrated that obesity, particularly
visceral obesity, is mainly involved in increasing the clinical risk of
metabolic and cardiovascular diseases [4,5]. Visceral adipose tissue
is now thought to play a pivotal role in metabolic syndrome and its
clinical consequences [6,7]. Targeting adipose tissue as a way to
treat these diseases has been investigated and tested [8]. For
example, peptide motif homing to white fat vasculature has been
developed using the phage display method. Conjugation with pro-
apoptotic peptide [9] and 11b-hydroxysteroid dehydrogenase type
1 (11b-HSD1) inhibitor [10] has also shown some promising
results.
Targeted delivery of drugs specific to adipose tissue has also
been envisioned as an effective method to treat metabolic disorders
[8,11,12]. However, while many potential targets of adipose tissue
have been established and candidate anti-obesity drugs have been
developed, none of those drugs specifically targets adipose tissue,
leading to undesirable side effects and lower efficacies. This results
from a limited knowledge of both cell-surface markers and
physicochemical traits specific to adipocytes that may otherwise
be exploited by circulating drugs.
Cell-SELEX is an established method used to select short
strands of nucelotides, called aptamers, which are able to
recognize target cells with high binding affinity and specificity.
Currently, aptamers have been generated from several cell lines
using this technique, including leukemia cells [13], glioblastoma
cells [14] and lung cancer cells [15]. Aptamers generated from this
method also provide an alternative tool for the discovery of cell-
surface biomarkers that can distinguish target cells from other cell
lines [16,17,18]. Moreover, aptamers can be easily engineered to
carry drug payloads, e.g., siRNAs (14). Given the ability of siRNAs
to knock down any gene of interest [19], turning off gene activity
via siRNAs could have therapeutic benefits. Drugs delivered in this
way will significantly enhance efficacy of drug therapy, while
avoiding side effects by unwanted action on other cell types.
By using 3T3-L1, as a positive adipocyte cell line, and both its
precursor preadipocyte and HepG2 as negative cell lines, we have
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ogy. This aptamer, denoted adipo-8, binds with high affinity only
to differentiated adipocytes, but not to preadipocytes or other cell
lines tested. By its ability to specifically recognize mature
adipocytes, this aptamer may also serve as a tool for adipocyte
biomarker discovery or even targeted delivery of drugs for the
treatment of adipocyte-related metabolic disease.
Results and Discussion
Enrichment of Aptamer Candidate Using Cell-SELEX
As described in Methods, cell-SELEX was used to select
aptamer candidates from a random library against the mature
adipocyte cell line 3T3-L1, a classical cell line for the study of
adipocytes in vitro. Upon differentiation, preadipocytes transform
from fibroblast-like cells into mature lipid-containing adipocytes
that share many characteristics of adipose cells in vivo. To exclude
aptamer candidates which bind to widely expressed membrane
proteins and their precursor preadipocytes, liver cancer cell line
HepG2 and undifferentiated preadipocytes were used for counter
selection.
The selection process was initiated by incubating 20 pmol of
library ssDNA’s with mature 3T3-L1 cells on a culture plate. After
washing, cells were collected, and those sequences binding to
target were eluted by heating the collecting solution to 95uC.
Sequences that bound to general cell surface targets were removed
by incubating the enriched pool with undifferentiated 3T3-L1 cells
(rounds 2,4,6,8,10 and 12–19) and HepG2 cells (rounds 3,5,7,9
and12). After each round, the eluted pool was PCR-amplified, and
the ssDNA recovered from the PCR product was used for the next
round of selection or for flow cytometry to monitor pool
enrichment. In contrast to other cell lines, differentiated 3T3-L1
adipocytes appeared as scattered dots in Side Scatter (SSC) and
Forward Scatter (FSC) flow cytometry, resulting from the speed of
adipogenesis among individual cells. In the dot plot, SSC reflects
the granularity of the cell, while FSC reflects the cell size. As
reported in the literature, 3T3-L1 cells will move upward in SSC
after differentiation into mature adipocytes duo to increased
cytoplasmic granularity caused by lipid droplet accumulation
[20,21]. Therefore, we set a cutoff point at ,200 so that a dot plot
above this value would be regarded as reporting differentiated,
mature adipocytes (Figure S1), while below this value, only
undifferentiated cells or cell debris were expected.
After a repeated positive-negative selection process, we observed
a clear dot plot shift from the original pool in flow cytometry by
incubating the pool enriched from the 13
th round with detached
adipocytes. In the dot plot Figure 1A, only a few cells appeared in
the upper right quadrant. When library pool was added to the
cells, we noticed a clear cell population in the left upper quadrant.
However, from the 6th to the 13th round pool, the cell population
shifted to the upper right quadrant. This tendency was clearly
illustrated in the histogram after gating; there was a clear shift
from left to right and from the 6th to the 16th pool. On the other
hand, from the 16
th to the 19
th pool, no further shift was noticed
(Figure 1B). These results indicated that the pool was successfully
enriched for sequences which bind to membrane targets expressed
by the mature adipocyte. These pools were then testing for binding
to the negative cell lines. None of the enriched pools could bind to
preadipocytes (Figure 1C) or HepG2 cells (Figure S2). Pool signals
were also reduced relative to background in the preadipocytes.
Since most pool sequences appeared to bind only surface markers
expressed in mature 3T3-L1 adipocytes, the pools generated from
rounds 13, 17, and 19 were gel-purified and sequenced.
Sequences Selected for Synthesis and Tests for Binding
Ability
Analysis of the enriched pools from rounds 13, 17, and 19,
indicated that they could all be categorized into 8 families based
on their sequence homology. Eight sequences showing highest
homology among the different pools were regarded as aptamer
candidates and synthesized. To further test the binding ability of
individual synthesized aptamers, biotin was coupled to the 59 end
of each aptamer candidate and streptavidin-PE was added for flow
cytometry. Among eight families tested, aptamers adipo-1 and
adipo-8 had the strongest binding (Figure 2A, B and Figure S3).
Detailed sequences are shown in Table 1. Aptamers (250 nM)
were also tested with control cells, and flow cytometry showed no
binding for either aptamer to preadipocytes or HepG2 cells.
As shown in Figure 2C, the binding Kd was also determined.
The calculated Kds of adipo-1 and adipo-8 to mature adipocytes
were 97.5613.5 nM and 17.865.1 nM, respectively. The binding
of these two aptamers to adipocytes was also verified by confocal
microscopy. As shown in Figure 3, almost no signal was observed
when initial library was incubated with the differentiated
adipocytes. However, when adipo-1 was incubated with cells, we
observed a round red signal located in the peripheral area of the
lipid-containing adipocytes. The signal became much stronger
when adipo-8 was incubated with mature adipocytes, indicating
that adipo-8 binds more strongly than adipo-1 to mature
adipocytes.
Specificity of Selected Aptamers
Next, the specific binding of the aptamers selected against 3T3-
l1 adipocytes was tested against the following cell lines: A549
(human lung adenocarcinoma epithelial cell line), Hct 116 cells
(colorectal carcinoma HCT-116 cells), human B cells, T cells,
CK562 (human erythroid leukemia), Ramos (human Burkitt’s
lymphoma cell line), PL45 (pancreatic cancer cells), MCF-7(breast
cancer cells) and A172 (human glioblastoma cell line). As shown in
Table 2, none of these cell lines showed binding to adipo-8, while a
slight shift could be observed in the A549, PL45, and MCF-7 cell
lines with adipo-1. After 3T3-L1 preadipocytes differentiate into
adipocytes, the following known proteins are expressed on the cell
membrane: GLUT4 [22], fatty acid transport protein (FATP1)
[23], fatty acid translocase (FAT/CD36) [24], plasma membrane
fatty acid binding protein (FABPpm) [25], Insulin-responsive
aminopeptidase (IRAP) [26], transferrin receptor (TfR) [27], and
Caveola and its proteins [28]. Since all of these proteins are also
expressed on either hepatocytes or muscle cells, we next tested the
binding ability of adipo-8 to hepG2 cells, WT hepatocytes, and
differentiated C2C12 cells (muscle cells). Again, however, no
binding shift could be observed, demonstrating that the selected
aptamer adipo-8 had high specificity to mature 3T3-L1 adipo-
cytes.
Characterization of Selected Aptamers
Two broad-spectrum serine proteases, trypsin and proteinase K,
with different mechanisms of action, were also used in the binding
studies of adipo-1 and adipo-8. After treatment of mature
adipocyte with trypsin for 30 min, there was no significant shift
back observed with adipo-1. However, the same treatment with
adipo-8 did result in a significant flow cytometry shift back
(Figure 4), indicating that the target molecule binding with adipo-8
is most likely some kind of protein. In addition, since selection
processes are generally performed at 4uC, we also tested whether
physiological temperature would affect the binding ability.
Aptamers adipo-1 and adipo-8 were incubated with target cells
Aptamers for Adipocyte Cells
PLoS ONE | www.plosone.org 2 May 2012 | Volume 7 | Issue 5 | e37789Figure 1. Flow cytometry results for selected pools (500 nM) with differentiated 3T3-L1 adipocyte and preadipocyte cells. (A) Dot
plot of flow cytometry with selected pools. (B) Flow cytometry assay to monitor the pool enrichment for differentiated 3T3 adipocytes. (C) The slight
shift of the respective pools to control 3T3-L1 preadipocyte was recovered by counter selection.
doi:10.1371/journal.pone.0037789.g001
Figure 2. Characterization of selected aptamers. Flow cytometry for the binding of PE/cy5-labled adipo-1 (A) and adipo-8 (B) to differentiated
3T3-L1 adipocytes at a concentration of 250 nM. (C) Kd determination for adipo8. Adipocytes were incubated with varying concentrations of PE-Cy5-
labeled adipo8 aptamer. The relative fluorescence intensity represents a ratio obtained through the following formula: relative fluorescensce
intensity= [(fluorescensce of aptamer - fluorescensce of library)/fluorescensce of library]. Error bars represent standard deviations. Each data point
was performed in triplicate.
doi:10.1371/journal.pone.0037789.g002
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observed at either temperature (Figure 5A,B).
Most currently known proteins expressed on the adipocyte
membrane surface after differentiation are responsive to insulin
stimulation. For example, proteins like GLUT4, FATP1, IRAP
have ten-fold increased expression in the cell membrane upon
insulin stimulation, while other proteins like FAT/CD36,
FABPpm, TfR increase two- to three-fold [29,30,31,32]. Conse-
quently, we tested whether insulin stimulation would affect the
binding ability of adipo-8. Serum starvation was performed before
the experiment to increase cellular response to insulin [33]. Cells
were then treated with insulin at a concentration of 160 nM before
flow cytometry. However, no significant shift changes were
observed with or without insulin stimulation (Figure 5C), indicat-
ing that this aptamer may bind to a protein that is not involved in
the insulin signaling pathway and, further, that it may be a possible
adipocyte biomarker not yet reported.
Binding of Selected Aptamer Adipo-8 to Frozen Adipose
Tissue
Since the selected aptamers specifically bound to mature
adipocytes, adipo-8 was tested to determine if it recognized
adipose tissue in a real clinical sample. To maximally preserve the
antigens at their original state on the adipocyte cell membrane,
epididymal adipose tissue was removed immediately after sacrifice
of the rat and used for frozen slide. After fixing with cold acetone
for 10 min, the frozen slide was used for staining with cy5-labled
adipo-8 and cy5-labeled library control. The results of fluores-
cence imaging and H&E staining are illustrated in Figure 6.
Although a very strong fluorescence was noted with adipose tissue,
very limited background fluorescence could be observed when
cy5-labeled library was incubated with the adipose tissue slide, a
result which is contrary to a previous report of high background
fluorescence when aptamers were incubated with formalin-fixed,
antigen-retrieved tissue [34,35]. We have also extended the
binding test to frozen slides from liver, skeletal muscle, pancreatic
tissue, and no fluorescence was observed (Figure S4). To explain
this inconsistency, it is proposed that the extensive intra- and
intermolecular crosslinks of tissue proteins induced by formalin
may increase the chance of nonspecific binding. Further investi-
gation is needed to evaluate this phenomenon by comparing the
effect of various modes of treating tissue sections for binding
ability.
Binding of Selected Aptamer Adipo-8 to Isolated Rat
Adipose Cells
Since the aptamer adipo-8 selected from 3T3-L1 cell line shows
binding to adipose tissue from S-D rats, we then investigated
whether this aptamer can bind with isolated adipocytes. The
adipose tissue contains different cells including adipocytes,
preadipocytes, fibroblasts, as well as tissue resident macrophages,
and vascular constituents [36]. Primary adipocytes were then
isolated from epididymal fat pads using methods described by
Sugihara [37]. The adipocytes can be easily separated from other
cell lines due to their floating properties after centrifugation. We
then tested the binding of cy5 labeled adipo-8 and the unselected
ssDNA library with floating adipocytes and pelleted cells from
digested adipose tissue separately. After incubation with the
floating adipocytes for 45 min, we observed strong fluorescence
under fluorescence microscopy, compared to the weak back-
ground fluorescence observed after incubation with the control
cy5-labled ssDNA library (Figure 7). Furthermore, no prominent
fluorescence could be seen when pelleted cells were incubated with
adipo-8, demonstrating that the aptamer probably did not bind to
other cells within adipose tissue.
In conclusion, we have selected two aptamers, adipo-1 and
adipo-8 that can recognize differentiated lipid-rich 3T3-L1
adipocytes by cell-SELEX with counter selection against pre-
adipocytes and HepG2 cells. In particular, adipo-8 showed high
specificity and affinity towards mature adipocytes with a Kd of
17.865.1 nM. Furthermore, adipo-8 showed no binding to any
other cell line tested, indicating that this probe could be used to
further characterize membrane protein expression after adipocyte
differentiation. Further tissue slides test revealed that the adipo-8
can recognize adipose tissue, while no staining can be observed on
tissue slides from rat liver, skeletal muscle, pancreas. These results
indicate that this aptamer has the high possibility of binding to a
molecular target specifically expressed in adipose tissue, especially
adipocytes. Several strategies have been proposed for the
treatment of metabolic disease via specific targeted delivery of
therapeutic drugs to adipose tissue. Supported by our findings, this
probe may also be exploited for direct targeted delivery of anti-
obesity drugs to adipose tissue. Another interesting finding in this
study is that little or no background fluorescence was observed
when aptamers were incubated with frozen slides from untargeted
tissue. Thus, performing SELEX on frozen tissue slides could be
explored as a new strategy for the discovery of new tissue specific
biomarkers.
Materials and Methods
Materials and Reagents
The 3T3-L1(Mouse 3T3-L1 preadipocytes), HepG2(liver hepa-
tocellular cells), A549 (human lung adenocarcinoma epithelial cell
line), Hct 116 cells(colorectal carcinoma HCT-116 cells), CK562
(human erythroid leukemia), Ramos (human Burkitt’s lymphoma
cell line), PL45 (pancreatic cancer cells), MCF-7(breast cancer
cells) and A172 (human glioblastoma cell line) were obtained from
ATCC (American Type Culture Collection, Manassas, VA, USA).
Human B cells and T cells were gifts from Lung-Ji Chang (Dept. of
Molecular Genetics and Microbiology, University of Florida).
C2C12 cells were kindly provided by Sally E. Johnson (Dept. of
Animal Sciences, University of Florida). Dulbecco’s modified
Eagle’s medium (DMEM), calf serum (CS), FBS, Oil Red O,
phosphate-buffered saline (PBS), paraformaldehyde, bovine serum
albumin (BSA), 3-isobutyl-1-methyxanthine (IBMX), insulin and
dexamethasone (DEX) were purchased from Sigma (St. Louis,
MO). Library and aptamers were synthesized on a 3400 DNA/
Table 1. Detailed sequences of aptamers used in the binding assay (primers are blue-colored).
Name Sequence
Adipo-1 ATGAGAAGCGTCGGTGTGGTTACTCCGGGCACTTGATATATCGATATGGAGAATAATGCACCCTGAGCGGGCTGGCAAGGCGCATA
Adipo-8 ATGAGAAGCGTCGGTGTGGTTAAACACGGAACGAAGGTGCAGGAAGATTTGTCGATGCGGTGCCTGAGCGGGCTGGCAAGGCGCATA
doi:10.1371/journal.pone.0037789.t001
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PLoS ONE | www.plosone.org 4 May 2012 | Volume 7 | Issue 5 | e37789Figure 3. Confocal images of aptamers stained with cultured differentiated 3T3-L1 adipocytes. Cells were incubated with aptamers
conjugated with biotin, and binding events were observed with PE-conjugated streptavidin. (A) unselected PE-labeled library; (B) adipo-1; (C) and
adipo-8. The final concentration of the aptamers in the binding buffer was 250 nM. (Left) fluorescence and (Right) optical images of differentiated
3T3-L1 adipocytes.
doi:10.1371/journal.pone.0037789.g003
Aptamers for Adipocyte Cells
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sequences were then deprotected in AMA (ammonium hydroxide/
40% aqueous methylamine 1:1) and purified by reversed-phase
HPLC (ProStar, Varian, Walnut Creek, CA, USA). Taq-
polymerase, dNTPs and other reagents were purchased from
Takara. PCR was performed on a Biorad Thermocycler. Trypsin
and Proteinase K were purchased from Fisher Biotech.
Cell Culture and Staining
The 3T3-L1 preadipocytes were cultured in DMEM with 10%
calf serum at 37uC in a 10% CO2 incubator. The cells were
differentiated as described previously [38,39]. Briefly, 3T3-L1 cells
were grown to confluency in 10% calf serum/DMEM. Two days
post-confluency (DAY 0), cell differentiation was initiated by
adding MDI media (DMEM containing 10% FBS, 0.5 mM 3-
isobutyl-1-methylxanthine, 1 mM dexamethasone, and 1.67 mM
insulin). After 48 h (DAY 2), the incubation medium was replaced
with insulin media (DMEM containing 10% FBS, 1.67 mM
insulin). Two days later (DAY 4), the medium was changed to
10% FBS/DMEM. Cells were incubated with 10% FBS/DMEM
every two days thereafter. Full differentiation was usually achieved
by DAY 8. On DAYS 0, 4, 6, 8 and 10, cells were fixed with 4%
formalin in PBS (pH 7.4) and stained with Oil Red O to evaluate
the differentiation rate. Differentiated 3T3-L1 cells at DAY 10
were used for subsequent experiments. All other cell lines used for
selectivity assays were cultured according to ATCC specifications.
Cell-SELEX Procedure
The library of synthetic DNAs, composed of a central
randomized sequence of 45 nucleotides flanked by two 20-nt
primer hybridization sites (59-ATGA-
GAGCGTCGGTGTGGTA-N45-TACTTCCGCACCCT
CCTACA-39), was amplified using a FITC-labeled 59-primer (59-
FITC-ATGAGAGCGTCGGTGTGGTA-39) and a biotin-la-
beled 39-primer (59-biotin-TACTTCCGCACCCTCCTACA-39).
Cell-SELEX was performed as previously described [40]. Briefly,
the ssDNA pool (100 pmol) in 400 mL binding buffer was
denatured by heating to 95uC for 5 min and then cooling on ice
for 5 min for better folding. The ssDNA pool was then incubated
with differentiated 3T3-L1 adipocytes at 4uC for 1 hour. After
washing, cells were collected in 300 mL binding buffer in a 1.5 mL
tube, and the bound ssDNAs were eluted by heating at 95uC. After
centrifugation, the supernatant was incubated with undifferentiat-
ed 3T3-L1 preadipocytes or HepG2 cells for counter selection.
After centrifugation, the supernatant was PCR-amplified with
FITC- and biotin-labeled primers. The selected sense ssDNA was
separated from the biotinylated antisense ssDNA strand by
streptavidin-coated Sepharose beads (Amersham Pharmacia Bio-
sciences) in 0.2 M NaOH. The purified ssDNAs were then used
for the next screening library or for pool enrichment monitored by
flow cytometry.
Flow Cytometric Analysis
Mature adipocytes and undifferentiated precursors were first
washed with PBS and detached with nonenzymatic dissociation
buffer for 15 min. After washing, 50610
4 cells were incubated
with FITC-labeled ssDNA pool dissolved in 200 mL binding buffer
at a final concentration of 250 nM for 45 min. Cells were washed
twice with 1 mL washing buffer and resuspended in 200 mL
binding buffer. Fluorescence was determined with a FACScan
cytometer (BD Immunocytometry Systems) by counting 30,000
events. The FITC-labeled unselected ssDNA library was used as a
negative control. When the level of enrichment reached a plateau
Table 2. Relative binding of aptamer adipo-1 and adipo-8 with different cell lines.
3T3-L1 A549
Human B
cell
Human T
cell
Hct
116
CK
562 Ramous PL45 MCF-7 A172 HepG2
WT
hepatocytes C2C12
Adipo-1 ++ + 222 2 2++22 2 2
Adipo-8 +++ 2 2 2 2 2 2 2222 2 2
doi:10.1371/journal.pone.0037789.t002
Figure 4. Preliminary determination of the nature of the molecular targets to which aptamers bind. Effect of trypsin treatment on the
binding ability of adipo-1 (A) and adipo-8 (B) to differentiated 3T3-L1 adipocytes. The concentration of aptamers in the binding buffer was 250 nM.
doi:10.1371/journal.pone.0037789.g004
Aptamers for Adipocyte Cells
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submitted for sequencing.
Affinity Tests of Aptamers
The binding affinity of aptamers was determined by incubating
differentiated 3T3-L1 cells (5610
5) on ice for 30 min in the dark
with varying concentrations of biotin-labeled aptamer in a 200 mL
volume. Cells were washed three times with 1000 mL WB,
followed by resuspension in 150 mL BB containing streptavidin-
PE for another 15 min. After washing, cells resuspended in 200 mL
washing buffer were then subjected to flow cytometry, with 59-
biotin-labeled library as negative control. All of the experiments
for binding affinity were repeated at least three times. The relative
fluorescence intensity represents a ratio obtained through the
Figure 5. Flow cytometry assays to assess if aptamers’ binding ability to mature adipocytes can be influenced by temperature and
insulin stimulation. Effects of temperature (A, B) and insulin stimulation (C) on the binding ability of adipo-1 and adipo-8 (250 nM) to differentiated
3T3-L1 adipocytes.
doi:10.1371/journal.pone.0037789.g005
Figure 6. (A) HE staining of frozen adipose tissue from SD rats. (B) Adipose tissue frozen sections stained with 200 nM Cy5-labeled library
(250 nM) (C) Adipose tissue frozen sections stained with 200 nM Cy5-labeled adipo-8 (250 nM).
doi:10.1371/journal.pone.0037789.g006
Aptamers for Adipocyte Cells
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censce of aptamer - fluorescensce of library)/fluorescensce of
library]. By using SigmaPlot (Jandel, San Rafael, CA), the
equilibrium dissociation constants (Kd) of the selected aptamers
to cells were calculated by fitting the dependence of fluorescence
intensity of specific binding on the concentration of the aptamers
to the equation Y= Bmax X/(Kd + X).
Confocal Imaging of Cells Bound with Aptamer
For confocal imaging, the biotin-labeled aptamers and unse-
lected control ssDNA pools were incubated with cells and washed
as described for flow cytometry. After incubation with BB
containing streptavidin-PE, cells were washed and subjected to
confocal imaging with an Olympus FV500-IX81 confocal
microscope. A 5-mW, 488-nm He-Ne laser was the excitation
source for the phycoerythrins(PE) throughout the experiments.
Twenty-five microliters of cell suspension bound with biotin-
streptavidin-PE-labeled ssDNA were dropped on a thin glass slide
placed above a 60x oil-immersion objective (PLAPO60XO3PH)
with a numerical aperture of 1.40 (Olympus).
Selectivity and Specificity
To determine the cell specificity of the selected aptamers, cell
lines, including A549, Hct 116 cells, human B cells, T cells,
CK562, Ramos, PL45, MCF-7, C2C12, and HepG2 cells, were
used in binding assays by flow cytometry, as described above.
Figure 7. Molecular recognition of adipo-8 with isolated adipocyte. Fluorescence image of isolated mature adipocyte stained by cy5-labled
adipo-8 (A), library (B). Fluorescence image of isolated pelleted cells of from collagenase-digested adipose tissue stained by cy5-labled adipo-8 (C).
The final concentration of the aptamers in the binding buffer was 250 nM. Optical (Left) and fluorescence (Right) image of adipocyte and pelleted
cells.
doi:10.1371/journal.pone.0037789.g007
Aptamers for Adipocyte Cells
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Aptamer Binding
Target cells (differentiated adipocytes) were detached using a
nonenzymatic cell dissociation solution. After resuspension in WB,
the cells were washed with 3 mL of PBS and then incubated with
1 mL of 0.05% trypsin/0.53 mM EDTA in HBSS or 0.1 mg/mL
proteinase K in PBS at 37uC for 15 and 30 min, respectively. Pure
FBS was added to quench the proteinases. After washing with
2 mL of BB, the treated cells were used for binding assays, as
described above. The binding stability of selected aptamers was
tested by incubating aptamers with adipocytes at 37uC, while
aptamers incubated on ice were used as the positive control,
followed by flow cytometry.
Effect of Insulin on Binding Ability of Adipo-8
After serum starvation for 20 hours, mature adipocytes were
incubated with DMEM media with 160 nM insulin for 10 min.
Afterwards, cells were chilled on ice and incubated with biotin-
coupled aptamer for 30 min. After washing, cells were incubated
with streptavidin-PE dye for 15 min. After washing, cells were
detached with nonenzymatic dissociation buffer for 20 min and
used for flow cytometry.
Staining of Rat Adipose Tissue Frozen Sections Using
Selected Aptamers
Male Sprague-Dawley rats (n=4, 200–250 g) were supplied by
the Experimental Animal Center of Central South University. All
procedures performed on the animals were in compliance with the
Chinese Council of Animal Care guidelines. All experimental
animals were approved by the Animal Care and Use Committee
of XiangYa Hospital, Central South University. Rats were
sacrificed by vertebral dislocation. After fresh segments of
epididymal adipose, liver, skeletal muscle, or pancreatic tissue
were frozen, they were embedded in optimal cutting temperature
(OCT) compound, and transverse sections (10 mm) were generated
with a cryostat, followed by mounting on charged glass slides.
Sections were fixed with cold acetone for 10 minutes at room
temperature and washed either for H&E staining or for
fluorescence aptamer staining. For fluorescence aptamer staining,
tissue sections were blocked with binding buffer containing 10%
BSA and 1 mM tRNA at 4uC for 60 min and then dropped with
300 mL of 250 nM cy5-labeled aptamers in binding buffer. After
incubation for 45 minutes, these tissue sections were washed three
times with binding buffer. Finally, the stained sections were
imaged by fluorescence microscopy (Nikon, Japan). The excitation
wavelength was 633 nm, emission fluorescence was detected using
a 670 nm filter, and the exposure time was 150 ms.
Preparation and incubation of adipose cells with selected
aptamers for fluorescence microscopy. Male Sprague-
Dawley rats were used to obtain primary adipose cells as described
previously [37]. Briefly, the epididymal fat pads were removed and
transfered to 5.5 mL prewarmed KRH buffer (120 mM NaCl,
5.2 mM KCl, 2.5 mM CaCl2, 1.2 mM KH2PO4, 1.2 mM
MgSO4, 15 mM NaHCO3, 10 mM HEPES, 5.0 mM D-glucose,
3% BSA, pH 7.4). The fat pads were then minced with a sharp
scissors for 2 min, and 15 mg collagenase type dissolved in 0.5 mL
KRH buffer was then added to the mixture. After incubating in a
shaking water bath with rapid shaking (120 cycles/min) for 60 min
at 37uC, the cells were gently passed through stainless mesh (pore
size 300 mesh). After centrifugation at 400 g at room temperature
for 1 min, adipocyte (floating cells) and pelleted cells were
resuspended separately in 30 mL fresh buffer (37uC). The
centrifugation and washing were repeated three times. The cells
were resuspended in 3 mL binding buffer (approx 2.5610
6 cells/
mL). For fluorescence microscopy, the cy5-labeled aptamers and
unselected control ssDNA pools were incubated with isolated rat
adipose cells. The infranatant was withdrawn, and the floating
cells were washed three times and used for fluorescence
microscopy. The pelleted cells were incubated and washed as
described for flow cytometry. Twenty-five microliters of cell
suspension incubated with cy5-labeled aptamers or ssDNA were
dropped on a thin glass slide and subjected to fluorescence
microscopy as described above with an exposure time of 150 ms.
Supporting Information
Figure S1 Dot plots of side scatter versus forward scatter of 3t3-
L1 cells generated from flow cytometric analysis of levels of
granularity at 0, 10 days after induction. The region above the bar
was gated to include the differentiated 3T3-L1 cells.
(TIF)
Figure S2 Flow cytometry assay of selected pool with negative
HepG2 cells.
(TIF)
Figure S3 The binding curve of adipocytes incubated with
varying concentrations of PE-Cy5-labeled adipo8 aptamer(A), PE-
Cy5-labeled adipo1(B) and their unselected library. (Error bars:
SD, N=3).
(TIF)
Figure S4 (Upper) H&E staining of frozen slides of liver (A),
skeletal muscle, (B) and pancreatic tissue (C) from SD rat. (Lower)
250 nM adipo-8 applied to frozen slides of different tissues. (Lower.
Images were obtained at 1006magnification.
(TIF)
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